Success Story: Thanks to Premium Processing, an Indian Research Associate & Biosafety Level-3 (BSL3) Facility Director got his EB1-B Petition Approved in the Field of Molecular Pathogenesis in just 13 Days

Client’s Testimonial:

“Thank you for your message. It has been such a pleasure to work with you and your firm.”

On January 5^th, 2022, we received another EB-1B (Outstanding Professors and Researchers) approval for a Research Associate and Biosafety Level-3 (BSL3) Facility Director in the Field of Molecular Pathogenesis (Approval Notice).

General Field: Molecular Pathogenesis

Position at the Time of Case Filing: Research Associate and Biosafety Level-3 (BSL3) Facility Director

Country of Origin: India

State of Residence at the Time of Filing: Ohio

Approval Notice Date: January 5^th, 2022

Processing Time: 13 days (Premium Processing Requested)

Case Summary:

“By lining up [client’s] achievements from his novel research on fabricating stem cell organoids to study pathogenesis to his impressive citation and publication record, [client’s] consistent success and influence become clear. It is therefore without reservation that I state [client’s] continued research to be of paramount importance in progressing molecular pathogenesis ever forward.”

The above snippet is extracted out of one of the four recommendation letters our client, a research associate, and the biosafety level-3 (BSL3) facility director achieved in his field of molecular pathogenesis. He approached NAILG to help him acquire his EB-1B (Outstanding Professors and Researchers) petition approval. We made sure that he received the best legal assistance for the same.

Although to be qualified for the EB1-B category, the petition must:

Show international recognition as being outstanding in a specific academic area;
The foreign national must have at least 3 years of experience in teaching or researching in the academic area;
While no labor certification is required, there must be an offer of ongoing employment from the sponsoring employer.

Therefore, after reviewing his credentials, we found that our client has gathered an awe-inspiring record of success:

He received his Ph.D. in microbiology from India;
His research has resulted in 13 peer-reviewed scientific articles;
His publications have been cited 472 times according to Google Scholar, thereby signifying that these publications are widely acknowledged and counted upon in the field of his expertise;
He has conducted at least 3 reviews and serves on the editorial board of 2 journals.

Additionally, our client’s research addresses some of our nation’s most pressing issues in understanding human diseases. His strong background in molecular pathogenesis has allowed his research to be particularly original, with applications such as enhanced healthcare technologies and a deepened knowledge of diseases. Also, researchers from Norway, Germany, Ukraine, India, the United States, and many more have flagged our client’s research and featured it to support and flesh out their work.

We are therefore confident that he is more than capable of furthering his knowledge base in the chosen field and continuing his work in the United States of America. Thus, he received his EB-1B approval in just 13 days (thanks to premium processing) and has even filed an I-485 case with us.

We would like to thank him for trusting us in the whole immigration process and would like to send our best wishes for his future endeavors.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.